Cathay Industrial Biotech, Ltd Announces $135M in New Financing for Monomer and Bio-Polyamide Expansion

Chinese player to commercializing recent developed technology breakthroughs

Shanghai, Dec. 14, 2015 – Cathay Industrial Biotech, Ltd. (Cathay), a leading privately-held industrial biotechnology company focused on producing specialty bio-based chemicals, announced a new round of financing which will be used for additional production capacity at their existing Jinxiang facility and to build a new production site. This represents a significant expansion in their production capacity for their long chain dibasic acids (LCDA), 1,5-pentanediamine (DN-5) and downstream polyamide business. Funding for this expansion will be provided by a $135M investment from Shanxi Lu’an Mining (Group) Co. Ltd. and will commercialize recent Cathay-developed technology breakthroughs in both raw materials and production technology which significantly improve production efficiency and environmental impact. The LCDA expansion will be completed by 2Q 2016, and will be sufficient to meet the current global demand. Expansion of DN-5 and DN-5-based polyamides capacity will come on-line in late 2016.

“We are very excited to continue our growth in LCDA by multi-sourcing of raw materials from oil, plant materials and coal. In addition, we will be the first to have large-scale production capacity for DN-5 as well as launch a full line of bio-based DN-5 polyamides. The collaboration with Lu’An as well as recent Cathay’s development breakthroughs, will have a very significant impact to the production efficiency of all our bio-based polyamide monomers. We expect these developments will have very positive impact to this growing market,” commented Dr. Xiucai Liu, CEO of Cathay Industrial Biotech.

“We are excited to participate with Cathay in the venture. Not only will Lu’An contribute capital into this project but also follow-up investments for its infrastructure, raw materials and down-stream products. We expect significant synergies when combined with Cathay’s new technologies,” added Jinping Li, Chairman of Lu’An Group.

Cathay began production of C11 through C18 LCDA in 2003 and renewable dodecanedioic acid in 2008. Cathay has grown to be the global leader for LCDA within ten years.

Cathay’s DN-5 product is yet another innovative product from its first-of-its-kind large-scale commercialization of biomanufacturing in the world. DN-5 is a novel renewable diamine which can be largely used in polyamide and diisocyanate coatings markets.

Cathay will also produce renewable polyamides using DN-5, their LCDA and other monomers for the engineering polymers and textile segments under the trademarks Terryl™ and Ecopent™.

When describing Cathay’s vision to commercialize bio-based polyamides, Dr. Xiucai Liu, CEO of Cathay announced, “This is only another step for Cathay and its associated partners to commercialize downstream products from DN-5 based-biopolyamides. We expect to invest around RMB 20 billion over the next few years to realize this goal.”


About Cathay Industrial Biotech, Ltd.

Founded in 1997, Cathay is a leading industrial biotechnology company whose focus is exclusively on developing and commercializing economically viable industrial biotechnology solutions for the production of specialty chemicals, previously obtainable only by chemical routes. The results are cost-competitive specialty chemicals, many of which are renewable and have a significantly lower environmental production footprint. In addition, industrial biotechnology can economically produce a variety of chemicals that were unobtainable by traditional production chemistries.

Cathay has developed and commercialized bio-production technology for long chain diacids, bio-butanol and now 1,5-pentanediamine (DN-5). Cathay has the distinction of being the first, and currently only, industrial biotechnology company to gain a majority share of a global market from the chemically produced incumbents.

About Shanxi Lu’an Mining (Group) Co. Ltd

Lies in the southeast of Shanxi province, Lu’an Group is a mining, chemical and energy multi-industry enterprise. With total assets of RMB 108.1 billion yuan and over 45,000 staff, it is among China Top 100 Enterprises and Fortune Global 500 in 2015.

  • Keynote Address, “A Road Map to Develop Bio-butanol as Fuel”, by Mr. Paul Caswell, Executive VP of International Business Development, Cathay Industrial Biotech, at the International Conference on Next Generation Technologies for Bioenergy and Biomass Utilisation in Singapore, August 2-4, 2012 Download
  • Keynote Address “Development and Commercialization of Green Nylon”, by Dr. Xiucai Liu, Chairman and CEO, Cathay Industrial Biotech, at the 3rd Annual Next Generation Bio-Based Chemicals conference in San Diego, January 23, 2012 Download
  • Keynote Address “Commercialization of Cellulosic Biofuel in China”, by Dr. Xiucai Liu, Chairman and CEO, Cathay Industrial Biotech, at the 2nd Annual World Congress on Bioenergy in Xi’an, April 25, 2012 Download
  • Cathay CEO Dr. Xiucai Liu presents key region perspective on industrial biotech in China at 2011 Industrial Biotech World Conference in Amsterdam, Feb 23, 2011



Alex Kedo,
Cathay Industrial Biotech, Ltd.,
phone: +8621 5080 1916,


Cathay, press release, 2015-12-14.


Cathay Industrial Biotech Ltd.